Let's talk


Market access and evidence generation strategy

Our strategic services help clients to navigate uncertainties and maximise value throughout development and commercialisation of products.

We support commercial and development strategy, market access, and evidence generation, bringing together sector experts, experienced strategists and market leading analytics.

We link global value strategies to local health system needs and priorities

At LCP Health Analytics, we recognise that securing access and reimbursement for novel therapies demands a strategic approach tailored to each product and market. Our dedicated market access team goes beyond generic consulting models to provide an integrated, bespoke service reflecting your specific needs for value demonstration, pricing strategy, and payer engagement. The team has experience from HTA success from over 300 submissions globally.

We foster early payer involvement through our global payer network for value demonstration, access and pricing, enabling successful launches. We quantify the full range of tangible and intangible value elements of your therapy to payers and health systems using real-world evidence. We also have extensive experience in co-creating innovative outcome-based agreements responsive to healthcare priorities.

With real-world analytics integral to our market access approach, we stand distinct from typical market access consultancies through linking global value strategies to local health system needs and priorities. Our goal is to help you achieve broad, rapid and sustainable patient access.

We support our clients across the following areas:

Market access strategy

  • Assessment of the pricing and reimbursement landscape
  • Payer research/advisory boards to understand decision-drivers
  • Value story/messaging
  • Environment shaping
  • Market access strategy/roadmap

Evidence generation strategy

  • Evidence gap analysis
  • Data source landscaping
  • Assessment of HTA/regulatory acceptability
  • Development of cross-functional, real-world evidence strategy across the lifecycle

Commercial strategy

  • Business development/licensing evaluation
  • Opportunity and landscape assessment
  • TPP development

Get in touch

Contact us to learn more about how we can bring you clarity and insight in an increasingly complex life sciences and healthcare environment.

Contact us